Global Bovine Pericardial Tissue Valve 麻豆原创 Research Report 2025

Publication ID:

PB505254048

Publication Date:

May 19, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Bovine Pericardial Tissue Valve was valued at US$ 2527 million in the year 2024 and is projected to reach a revised size of US$ 4106 million by 2031, growing at a CAGR of 7.1% during the forecast period.
A Bovine Pericardial Tissue Valve is a type of biological heart valve made from the pericardium (the membrane surrounding the heart) of cows. These valves are treated and processed to be biocompatible and are typically used for heart valve replacement surgeries. The bovine tissue provides excellent durability and function as a valve material.
麻豆原创 Overview:
Bovine pericardial valves are commonly used in patients who require a bioprosthetic valve for conditions like aortic stenosis or mitral valve regurgitation. They are favored for their natural flexibility, reduced risk of clotting, and lower need for long-term anticoagulation compared to mechanical valves.
麻豆原创 Drivers:
Increased demand for bioprosthetic valves over mechanical valves due to their better long-term outcomes and reduced clotting risks.
Technological improvements in tissue preservation, leading to better valve longevity and patient outcomes.
Favorable clinical outcomes, especially in elderly patients and those at high risk for anticoagulant therapy complications.
麻豆原创 Opportunities:
Ongoing research into improving the durability and anti-calcification properties of bovine pericardial valves.
Expansion of the market in emerging economies where the prevalence of valvular heart disease is rising, but advanced healthcare options are still growing.
麻豆原创 Limitations:
Bovine pericardial valves typically have a shorter lifespan compared to mechanical valves, which may necessitate reoperation in younger patients.
Concerns about the long-term durability of bovine tissue and the potential for valve degeneration.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bovine Pericardial Tissue Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Pericardial Tissue Valve.
The Bovine Pericardial Tissue Valve market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bovine Pericardial Tissue Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bovine Pericardial Tissue Valve manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Edwards Lifesciences
St. Jude Medical
Meril Life Sciences
Balance Medical
Boston Scientific
Labor
Abbott
Colibri Heart Valve
Segment by Type
Stentless
Stented
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bovine Pericardial Tissue Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bovine Pericardial Tissue Valve in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Bovine Pericardial Tissue Valve 麻豆原创 Overview
1.1 Product Definition
1.2 Bovine Pericardial Tissue Valve by Type
1.2.1 Global Bovine Pericardial Tissue Valve 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Stentless
1.2.3 Stented
1.3 Bovine Pericardial Tissue Valve by Application
1.3.1 Global Bovine Pericardial Tissue Valve 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Bovine Pericardial Tissue Valve 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Bovine Pericardial Tissue Valve Revenue 2020-2031
1.4.2 Global Bovine Pericardial Tissue Valve Sales 2020-2031
1.4.3 Global Bovine Pericardial Tissue Valve 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bovine Pericardial Tissue Valve 麻豆原创 Competition by Manufacturers
2.1 Global Bovine Pericardial Tissue Valve Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Bovine Pericardial Tissue Valve Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Bovine Pericardial Tissue Valve Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bovine Pericardial Tissue Valve, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bovine Pericardial Tissue Valve, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bovine Pericardial Tissue Valve, Product Type & Application
2.7 Global Key Manufacturers of Bovine Pericardial Tissue Valve, Date of Enter into This Industry
2.8 Global Bovine Pericardial Tissue Valve 麻豆原创 Competitive Situation and Trends
2.8.1 Global Bovine Pericardial Tissue Valve 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Bovine Pericardial Tissue Valve Players 麻豆原创 Share by Revenue
2.8.3 Global Bovine Pericardial Tissue Valve Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bovine Pericardial Tissue Valve 麻豆原创 Scenario by Region
3.1 Global Bovine Pericardial Tissue Valve 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bovine Pericardial Tissue Valve Sales by Region: 2020-2031
3.2.1 Global Bovine Pericardial Tissue Valve Sales by Region: 2020-2025
3.2.2 Global Bovine Pericardial Tissue Valve Sales by Region: 2026-2031
3.3 Global Bovine Pericardial Tissue Valve Revenue by Region: 2020-2031
3.3.1 Global Bovine Pericardial Tissue Valve Revenue by Region: 2020-2025
3.3.2 Global Bovine Pericardial Tissue Valve Revenue by Region: 2026-2031
3.4 North America Bovine Pericardial Tissue Valve 麻豆原创 Facts & Figures by Country
3.4.1 North America Bovine Pericardial Tissue Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bovine Pericardial Tissue Valve Sales by Country (2020-2031)
3.4.3 North America Bovine Pericardial Tissue Valve Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bovine Pericardial Tissue Valve 麻豆原创 Facts & Figures by Country
3.5.1 Europe Bovine Pericardial Tissue Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bovine Pericardial Tissue Valve Sales by Country (2020-2031)
3.5.3 Europe Bovine Pericardial Tissue Valve Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bovine Pericardial Tissue Valve 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Bovine Pericardial Tissue Valve 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bovine Pericardial Tissue Valve Sales by Region (2020-2031)
3.6.3 Asia Pacific Bovine Pericardial Tissue Valve Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bovine Pericardial Tissue Valve 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Bovine Pericardial Tissue Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bovine Pericardial Tissue Valve Sales by Country (2020-2031)
3.7.3 Latin America Bovine Pericardial Tissue Valve Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bovine Pericardial Tissue Valve 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Bovine Pericardial Tissue Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bovine Pericardial Tissue Valve Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bovine Pericardial Tissue Valve Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bovine Pericardial Tissue Valve Sales by Type (2020-2031)
4.1.1 Global Bovine Pericardial Tissue Valve Sales by Type (2020-2025)
4.1.2 Global Bovine Pericardial Tissue Valve Sales by Type (2026-2031)
4.1.3 Global Bovine Pericardial Tissue Valve Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Bovine Pericardial Tissue Valve Revenue by Type (2020-2031)
4.2.1 Global Bovine Pericardial Tissue Valve Revenue by Type (2020-2025)
4.2.2 Global Bovine Pericardial Tissue Valve Revenue by Type (2026-2031)
4.2.3 Global Bovine Pericardial Tissue Valve Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Bovine Pericardial Tissue Valve Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bovine Pericardial Tissue Valve Sales by Application (2020-2031)
5.1.1 Global Bovine Pericardial Tissue Valve Sales by Application (2020-2025)
5.1.2 Global Bovine Pericardial Tissue Valve Sales by Application (2026-2031)
5.1.3 Global Bovine Pericardial Tissue Valve Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Bovine Pericardial Tissue Valve Revenue by Application (2020-2031)
5.2.1 Global Bovine Pericardial Tissue Valve Revenue by Application (2020-2025)
5.2.2 Global Bovine Pericardial Tissue Valve Revenue by Application (2026-2031)
5.2.3 Global Bovine Pericardial Tissue Valve Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Bovine Pericardial Tissue Valve Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Bovine Pericardial Tissue Valve Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Edwards Lifesciences
6.2.1 Edwards Lifesciences Company Information
6.2.2 Edwards Lifesciences Description and Business Overview
6.2.3 Edwards Lifesciences Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Edwards Lifesciences Bovine Pericardial Tissue Valve Product Portfolio
6.2.5 Edwards Lifesciences Recent Developments/Updates
6.3 St. Jude Medical
6.3.1 St. Jude Medical Company Information
6.3.2 St. Jude Medical Description and Business Overview
6.3.3 St. Jude Medical Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.3.4 St. Jude Medical Bovine Pericardial Tissue Valve Product Portfolio
6.3.5 St. Jude Medical Recent Developments/Updates
6.4 Meril Life Sciences
6.4.1 Meril Life Sciences Company Information
6.4.2 Meril Life Sciences Description and Business Overview
6.4.3 Meril Life Sciences Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Meril Life Sciences Bovine Pericardial Tissue Valve Product Portfolio
6.4.5 Meril Life Sciences Recent Developments/Updates
6.5 Balance Medical
6.5.1 Balance Medical Company Information
6.5.2 Balance Medical Description and Business Overview
6.5.3 Balance Medical Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Balance Medical Bovine Pericardial Tissue Valve Product Portfolio
6.5.5 Balance Medical Recent Developments/Updates
6.6 Boston Scientific
6.6.1 Boston Scientific Company Information
6.6.2 Boston Scientific Description and Business Overview
6.6.3 Boston Scientific Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boston Scientific Bovine Pericardial Tissue Valve Product Portfolio
6.6.5 Boston Scientific Recent Developments/Updates
6.7 Labor
6.7.1 Labor Company Information
6.7.2 Labor Description and Business Overview
6.7.3 Labor Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Labor Bovine Pericardial Tissue Valve Product Portfolio
6.7.5 Labor Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abbott Bovine Pericardial Tissue Valve Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Colibri Heart Valve
6.9.1 Colibri Heart Valve Company Information
6.9.2 Colibri Heart Valve Description and Business Overview
6.9.3 Colibri Heart Valve Bovine Pericardial Tissue Valve Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Colibri Heart Valve Bovine Pericardial Tissue Valve Product Portfolio
6.9.5 Colibri Heart Valve Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bovine Pericardial Tissue Valve Industry Chain Analysis
7.2 Bovine Pericardial Tissue Valve Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bovine Pericardial Tissue Valve Production Mode & Process Analysis
7.4 Bovine Pericardial Tissue Valve Sales and 麻豆原创ing
7.4.1 Bovine Pericardial Tissue Valve Sales Channels
7.4.2 Bovine Pericardial Tissue Valve Distributors
7.5 Bovine Pericardial Tissue Valve Customer Analysis
8 Bovine Pericardial Tissue Valve 麻豆原创 Dynamics
8.1 Bovine Pericardial Tissue Valve Industry Trends
8.2 Bovine Pericardial Tissue Valve 麻豆原创 Drivers
8.3 Bovine Pericardial Tissue Valve 麻豆原创 Challenges
8.4 Bovine Pericardial Tissue Valve 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Medtronic
Edwards Lifesciences
St. Jude Medical
Meril Life Sciences
Balance Medical
Boston Scientific
Labor
Abbott
Colibri Heart Valve

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.